Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Janney Montgomery Scott Initiates Coverage On FB Financial with Buy Rating

Janney Montgomery Scott analyst Feddie Stickland initiates coverage on FB Financial (NYSE:FBK) with a Buy rating.

byBenzinga Newsdesk

September 13, 2022

1 minute read

Janney Montgomery Scott analyst Feddie Stickland initiates coverage on FB Financial (NYSE:FBK) with a Buy rating.

News

‘Tesla is ordered to upgrade self-driving computer for free over ‘false advertising” -Electrek

By Michael Horton

Today, 3:52 AM

https://electrek.co/2022/12/12/tesla-ordered-upgrade-self-driving-computer-for-free-false-advertising/

TSLA

Moderna Sponsored ClinicalTrials.gov Listing For Co.’s ‘A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age,’ Shows Not Yet Recruiting

By Benzinga Newsdesk

Today, 3:52 AM

https://clinicaltrials.gov/ct2/show/NCT05085366

MRNA

Atlantic Equities Initiates Coverage On JD.com with Overweight Rating, Announces Price Target of $100

By Benzinga Newsdesk

Today, 3:52 AM

Atlantic Equities initiates coverage on JD.com (NASDAQ:JD) with a Overweight rating and announces Price Target of $100.

Goldman Sachs Is Bullish On Halliburton: What Investors Need To Know

By Nikhil Dayal

Today, 3:52 AM

Off the cusp of several challenging years, Halliburton Company (NYSE: HAL) has a more straightforward path to better returns and dividend growth, Goldman Sachs said in a stock upgrade.

HAL

Janney Montgomery Scott Initiates Coverage On FB Financial with Buy Rating

Related Posts

‘Tesla is ordered to upgrade self-driving computer for free over ‘false advertising” -Electrek

Moderna Sponsored ClinicalTrials.gov Listing For Co.’s ‘A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age,’ Shows Not Yet Recruiting

Atlantic Equities Initiates Coverage On JD.com with Overweight Rating, Announces Price Target of $100

Goldman Sachs Is Bullish On Halliburton: What Investors Need To Know